glp-1 news 2025 october 16 What's next for innovation: A primer on the race reshaping pharma and chronic disease care The expanding landscape of GLP-1

GLP-1 Agonists and Breast Cancer: What Patients Should Know For many living with breast cancer or managing long-term health after treatment, questions about new medications are commonand important

Both NHS and private access to weight loss injections have advantages, and find the right option for you can depend on factors such as: Cost Eligibility Speed of access to treatment If cost is your main concern and you meet the strict criteria, the NHS may be the right path

It wasn't until 2023 that the FDA issued a Black Box warning for potential risks of thyroid cancer along with several mandated label warnings that highlighted a potential risk for kidney failure and pancreatitis when taking Ozempic

Hydration is one of those habits

Why Higher Doses Cause More GI Problems GI side effects tend to worsen at higher doses because of increased receptor stimulation

Brain cell metabolism was preserved in one trial, and the other found reduced amyloid-beta in extracellular vesicles, but neither trial found that GLP-1 drugs reduced the build-up of amyloid-beta in the brain or helped stave off cognitive decline